1. |
BenZaken O, Shafat I, GingisVelitski S, et al. Low and high affinity receptors mediate cellular uptake of heparanase [J]. Int J Biochem Cell Biol, 2008; 40(3): 530542.
|
2. |
Reiland J, Sanderson RD, Waguespack M, et al. Heparanase degrades syndecan1 and perlecan heparan sulfate functional implications for tumor cell invasion [J]. J Biol Chem, 2004; 279(9): 80478055.
|
3. |
Xu X, Ding J, Rao G, et al. Estradiol induces heparanase1 expression and heparan sulphate proteoglycan degradation in human endometrium [J]. Hum Reprod, 2007; 22(4): 927937.
|
4. |
Sanderson RD, Yang Y, Suva LJ, et al. Heparan sulfate proteoglycans and heparanase-partners in osteolytic tumer growth and metastasis [J]. Matrix Biol, 2004; 23(6): 341352.
|
5. |
Cohen I, Pappo O, Elkin M, et al. Heparanase promotes growth, angiogenesis and survival of primary breast tumors [J]. Int J Cancer, 2005; 118(7): 16091617.
|
6. |
Ilan N, Elkin M, Vlodavsky I. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis [J]. Int J Biochem Cell Biol, 2006; 38(12): 20182039.
|
7. |
Doviner V, Maly B, Kaplan V, et al. Spatial and temporal heparanase expression in colon mucosa throughout the adenomacarcinoma sequence [J]. Mod Pathol, 2006; 19(6): 878888.
|
8. |
肖毅, 冯云路, 钱家鸣, 等. 乙酰肝素酶在结直肠癌中的表达及意义 [J]. 中国普外基础与临床杂志, 2007; 14(4): 442447.
|
9. |
Shinyo Y, Kodama J, Hongo A, et al. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer [J]. Ann Oncol, 2003; 14(10): 15051510.
|
10. |
Hannon GJ. RNA interference [J]. Nature, 2002; 418(6894): 244251.
|
11. |
Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells [J]. Science, 2002; 296(5567): 550553.
|
12. |
Zhang ZH, Chen Y, Zhao HJ, et al. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo [J]. Cancer Biol Ther, 2007; 6(4): 587595.
|
13. |
Sommerfeldt N, Beckhove P, Ge Y, et al. Heparanase: a new metastasisassociated antigen recognized in breast cancer patients by spontaneously induced memory T lymphocytes [J]. Cancer Res, 2006; 66(15): 77167723.
|
14. |
Sambrook J, Russell DW著. 黄培堂译. 分子克隆实验指南 [M]. 第4版. 北京: 科学出版社, 2005: 2628.
|
15. |
王守立, 姚辉华, 董亮, 等. 脂质体介导TGF1 shRNA转染的方法 [J]. 苏州大学学报(医学版), 2008; 28(2): 222225.
|
16. |
任亮, 朱宝芹, 张轶博, 等. 利用软件Primer Premier 5.0 进行PCR引物设计的研究 [J]. 锦州医学院学报, 2004; 25(6): 4345.
|
17. |
翟中会, 陈希南, 王娟. 利用Primer Premier 5.0进行引物设计 [J]. 西北医学教育, 2008; 16(4): 695698.
|
18. |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using realtime quantitative PCR and the 2-△△CT method [J]. Methods, 2001; 25(4): 402408.
|
19. |
唐永凯, 贾永义. 荧光定量PCR数据处理方法的探讨 [J]. 生物技术, 2008; 18(3): 8991.
|
20. |
Kelly T, Miao HQ, Yang Y, et al. High heparanase activity in multiple myeloma is associated with elevated microvessel density [J]. Cancer Res, 2003; 63(24): 87498756.
|
21. |
Vlodavsky I, Ilan N, Nadir Y, et al. Heparanase, heparin and the coagulation system in cancer progression [J]. Thromb Res, 2007; 120(Suppl 2): S112S120.
|
22. |
Maxhimer JB, Quiros RM, Stewart R, et al. Heparanase1 expression is associated with the metastatic potential of breast cancer [J]. Surgery, 2002; 132(2): 326333.
|
23. |
Gtte M, Yip GW. Heparanase, hyaluronan, and CD44 in cancers: a breast carcinoma perspective [J]. Cancer Res, 2006; 66(21): 1023310237.
|
24. |
童强, 舒晓刚, 卢晓明, 等. STAT3基因短发夹RNA表达质粒的构建及其对胃癌细胞生长和侵袭的抑制作用 [J]. 中国普外基础与临床杂志, 2009; 16(1): 611.
|
25. |
刘利平, 陈孝平, 杨盛力, 等. 沉默缺氧诱导因子1 对肝癌细胞化疗敏感性影响及相关机理的研究 [J]. 中国普外基础与临床杂志, 2008; 15(4): 234239.
|